Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|November 7, 2022
Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axisDaniel Martin Klotz, Jan Dominik Kuhlmann, Theresa Link, et al.
Cancers|February 15, 2022
<i>FNTB</i> Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast CancerHagen Sjard Bachmann, Dominik Jung, Theresa Link, et al.
Gynecologic Oncology|September 27, 2020
The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparibCatharina Wichmann, Daniel Martin Klotz, Hans-Joachim Zeiler, et al.
Molecular Oncology|March 31, 2019
Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancerTheresa Link, Jan Dominik Kuhlmann, Dennis Kobelt, et al.
Clinical Chemistry and Laboratory Medicine|April 5, 2024
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNAOliver Kutz, Stephan Drukewitz, Alexander Krüger, et al.
Pageof 6